Khairy: Malaysia, Merck sign agreement for Covid-19 drug Molnupiravir

By Joseph Kaos Jr

PUTRAJAYA: Malaysia has signed an agreement with Merck Sharp & Dohme (MSD) to procure antiviral medicine Molnupiravir for Covid-19 treatment.

Health Minister Khairy Jamaluddin said the government signed a letter of undertaking on Thursday (Oct 7) to procure 150,000 courses of Molnupiravir to treat Covid-19 patients.

Save 30% OFF The Star Digital Access

Monthly Plan

RM 13.90/month

RM 9.73/month

Billed as RM 9.73 for the 1st month, RM 13.90 thereafter.

Best Value

Annual Plan

RM 12.33/month

RM 8.63/month

Billed as RM 103.60 for the 1st year, RM 148 thereafter.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!
Covid-19 , Malaysia , Merck , Khairy Jamaluddin , Molnupiravir , Covid-19 drug , Health Minister , Health Ministry

Next In Nation
Sabah polls: Voters will punish parties that fail to stand firm, says MCA sec-gen
Wanita MCA ‘ready to lead’ as young women membership surges 145%
Immigration Dept aims for full digitalisation and zero public complaints, says DG
Brothers killed after motorcycle crashes into guardrail on NSE
Suspected tiger attack behind dead, missing cattle near Chemor, say Perak cops
Exempt food industry from paying EPF for foreign workers, urges association
Diploma student dies from high blood pressure complications in Melaka
Airasia’s hijab uniform option a progressive, commendable move, says Mohd Na’im
More flood victims return home in Perak, Selangor
Thunderstorm warning for four states, Labuan until 1pm

Trending in News

Others Also Read

Load more

Copyright © 1995- Star Media Group Berhad [197101000523 (10894-D)]

Best viewed on Chrome browsers.